Hitachi High-Tech, a trading company handling a variety of products, agreed to invest in Invivoscribe, a developer of medical diagnostic tools. Financial terms were not disclosed. "Hitachi High-Tech has been strengthening its molecular diagnosis business centered on genetic testing. By combining Invivoscribe’s testing service business with our experiences gained from the equipment business, we aim to build a unique business model and provide a wide range of services to medical professionals," Yoshimitsu Takagi, Hitachi High-Tech Vice President, Executive Officer and General Manager.